Fludarabine Phosphate

Product NDC
42658-024
11-digit product format
426580024
Labeler code
42658
Product ID
42658-024_5b82547e-11ca-a21a-e063-6294a90a025b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Fludarabine Phosphate
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Hisun Pharmaceuticals USA, Inc.
Application
ANDA220196
Marketing category
ANDA
Marketing start
2026-09-01
Substance
FLUDARABINE PHOSPHATE
Active strength
25 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A220196-001FLUDARABINE PHOSPHATEFLUDARABINE PHOSPHATE50MG/2ML (25MG/ML)INJECTABLE / INJECTIONRS2026-07-23

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A220196-001FLUDARABINE PHOSPHATE50MG/2ML (25MG/ML)INJECTABLE / INJECTIONRS2026-07-23d4dbc9d85df4…
2026-10-15 13:18:302026-09A220196-001FLUDARABINE PHOSPHATE50MG/2ML (25MG/ML)INJECTABLE / INJECTIONRS2026-07-23c2088c7a36db…
2026-09-14 22:38:342026-08A220196-001FLUDARABINE PHOSPHATE50MG/2ML (25MG/ML)INJECTABLE / INJECTIONRS2026-07-2384e616aacf4f…
2026-08-18 06:07:402026-07A220196-001FLUDARABINE PHOSPHATE50MG/2ML (25MG/ML)INJECTABLE / INJECTIONRS2026-07-23caaa826d4ba7…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Fludarabine Phosphate
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FLUDARABINE PHOSPHATE25 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1X9VK9O1SCInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1740865Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
291f6ee2-f5d2-ae6c-e063-6294a90a5951Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Fludarabine PhosphateFLUDARABINE PHOSPHATEHisun Pharmaceuticals USA, Inc.291f6ee2-f5d2-ae6c-e063-6294a90a59512026-09-20Warnings, Adverse reactionsExact identifier
application applno (ANDA): 220196
application number: ANDA220196
ndc (product): 42658-024

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
42658-024-01426580024011 VIAL, SINGLE-DOSE in 1 CARTON (42658-024-01) / 2 mL in 1 VIAL, SINGLE-DOSE2026-09-01NoNoCurrent